Related Experiment Video
Updated: Aug 4, 2026

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
Published on: November 1, 2011
Increased induction of apoptosis by a Sendai virus mutant is associated with attenuation of mouse pathogenicity
1Department of Microbiology, Kobe University School of Medicine, Japan. masae@med.kobe-u.ac.jp
Abstract:
An avirulent mutant of Sendai virus, Ohita-MVC11 (MVC11), was generated from a highly virulent field strain, Ohita-M1 (M1), through successive passages in LLC-MK2 cell cultures (M. Itoh, Y. Isegawa, H. Hotta, and M. Homma, J. Gen. Virol. 78:3207-3215, 1997). In LLC-MK2 cells, MVC11 induced a high degree of apoptotic cell death that was demonstrated by chromatin condensation of the nucleus and DNA fragmentation, and production of MVC11 declined markedly after prolonged culture. On the other hand, M1 did not induce prominent apoptosis and maintained high virus titers. In primary mouse pulmonary epithelial cell cultures, M1 replicated rather slowly to reach maximum level of virus production at 3 days postinfection, and high levels of virus production were maintained thereafter without causing apoptosis. In contrast, MVC11, which produced 20 times more progeny virus than M1 at 1 day postinfection, induced a high degree of apoptotic cell death before the virus replication cycle was completed. Accordingly, the production of progeny virus was strongly inhibited thereafter. In the lungs of mice infected with MVC11, virus antigens and signals of DNA fragmentation detected by the in situ terminal deoxynucleotidyltransferase-mediated dUTP nick end-labeling technique colocalized in bronchial epithelial cells, clearly demonstrating that infection by MVC11 triggered apoptosis in vivo as well as in vitro. These results suggest the possibility that induction of apoptosis by MVC11 plays an important role in attenuation of mouse pathogenicity by restricting progeny virus production in the lung. The C protein was shown to have the capacity to induce apoptosis, and the increased level of the C protein in MVC11-infected cells was considered to account partly, if not entirely, for the induction of apoptosis.
Insights
An avirulent Sendai virus mutant, MVC11, induces apoptosis in lung cells, restricting virus production and reducing pathogenicity. This programmed cell death is linked to increased C protein levels, aiding in viral attenuation.
Area of Science:
- Virology
- Cell Biology
- Immunology
Background:
- Sendai virus (SeV) exhibits varying virulence, with field strains like Ohita-M1 (M1) being highly virulent.
- Avirulent mutants can be generated through cell culture passages, offering potential for vaccine development or understanding virulence factors.
Purpose of the Study:
- To investigate the mechanism of attenuation of the avirulent Sendai virus mutant Ohita-MVC11 (MVC11) compared to its virulent parent strain M1.
- To determine the role of apoptosis in the pathogenicity and replication of MVC11 in vitro and in vivo.
Main Methods:
- Comparative analysis of viral replication and apoptosis induction in LLC-MK2 and primary mouse pulmonary epithelial cells infected with M1 and MVC11.
- In situ terminal deoxynucleotidyltransferase-mediated dUTP nick end-labeling (TUNEL) assay to detect DNA fragmentation in infected mouse lungs.
Main Results:
- MVC11 induced significant apoptosis (chromatin condensation, DNA fragmentation) in LLC-MK2 cells, leading to reduced virus production.
- In mouse lung cells, MVC11 triggered apoptosis, inhibiting viral replication, while M1 replicated efficiently without inducing prominent apoptosis.
- Virus antigens and DNA fragmentation colocalized in MVC11-infected bronchial epithelial cells in vivo, confirming apoptosis induction.
Conclusions:
- Apoptosis induction by MVC11 plays a crucial role in its attenuated mouse pathogenicity by limiting progeny virus production.
- The C protein of MVC11 is implicated in triggering apoptosis, contributing to the observed attenuation.
- Understanding the interplay between viral replication, apoptosis, and host response is key to developing safer viral therapeutics.
Related Concept Videos
In-vitro Mutagenesis
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

